Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
New research reveals teclistamab and daratumumab significantly enhance progression-free survival in multiple myeloma, ...
HealthDay on MSN
American Society of Hematology, Dec. 6 to 9
The annual meeting of the American Society of Hematology was held from Dec. 6 to 9 in Orlando, Florida, and attracted ...
Guidelines recommend older adults with newly diagnosed AML should be offered antileukemic therapy over best supportive care.
Oral histories, journal articles, and unpublished materials from the ASCO History of Oncology Archive were reviewed to analyze these events closely. In 1972, the American Board of Internal Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback